DUSPATALIN

This brand name is authorized in Nigeria. It is also authorized in Brazil, Cyprus, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Lithuania, Mexico, Poland, Romania, Singapore, Spain, Tunisia, Turkey.

Active ingredients

The drug DUSPATALIN contains one active pharmaceutical ingredient (API):

1	Mebeverine UNII 15VZ5AL4JN - MEBEVERINE HYDROCHLORIDE
	Mebeverine is a musculotropic antispasmodic with a direct action on the smooth muscle of the gastrointestinal tract, relieving spasm without affecting normal gut motility.
	Read more about Mebeverine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-1302	Tablet	Duspatalin Tablets TAB 135 mg 1 x 50's	Tablet	28/01/2021

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DUSPATALIN Modified release capsule, hard	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A03AA04	Mebeverine	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AA Synthetic anticholinergics, esters with tertiary amino group
Discover more medicines within A03AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500214050031608, 500216020034303
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00009923, 00009946, 00055248, 00111573, 01184700, 01184717, 02742349, 02742355, 06467124, 06467130, 12490966, 16352899
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29.200-03-10, 5860-MEE-0121
EE	Ravimiamet	1136696, 1885181
ES	Centro de información online de medicamentos de la AEMPS	53900
FR	Base de données publique des médicaments	61703401
HK	Department of Health Drug Office	32074, 38954
LT	Valstybinė vaistų kontrolės tarnyba	1015607, 1070284, 1079069, 1081606
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	259M2009, 314M2002
NG	Registered Drug Product Database	04-1302
PL	Rejestru Produktów Leczniczych	100020985, 100078507, 100261074, 100266746, 100274036, 100292241, 100300294, 100301365, 100303619, 100306428, 100312156, 100325064, 100332710, 100343375, 100348616, 100350079, 100369512, 100385400, 100390104, 100392379, 100407661, 100421098, 100421721, 100424702, 100426322, 100429504, 100433658, 100457086, 100464331
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69081001, W69081002
SG	Health Sciences Authority	07666P
TN	Direction de la Pharmacie et du Médicament	9003741
TR	İlaç ve Tıbbi Cihaz Kurumu	8699820030360, 8699820120030, 8699820700041